LIST OF ONGOING STUDIES AS ON 12th FEBRUARY, 2024
Pharmacokinetic drug-drug interactions between first line anti-TB and anti-diabetic drugs
Dr. A.K. Hemanth Kumar
Pharmacokinetics of second-line anti-TB drugs in children and adolescents with MDR TB
Dr. A.K. Hemanth Kumar
Bioavailability of fixed dose combination of first line anti-TB drugs in patients with pulmonary tuberculosis
Dr. A.K. Hemanth Kumar
Molecular cloning and characterization of full-length infectious Transmitted/Founder HIV-1 viruses
Dr. Luke E. Hanna
Identification of broadly neutralizing antibodies against HIV
Dr. Luke E. Hanna
Inflammation and aging in HIV-infected individuals on long-term antiretroviral therapy
Dr. Luke E. Hanna
Identification of biomarkers that can predict progression from Latent Tuberculosis Infection to active TB disease
Dr. Luke E. Hanna
National HIV Cohort Program – Cohorts of HIV Resistance and Progression in Indian Children and Adults (CoHRPICA)
Dr. Luke E. Hanna
Impact of malnutrition on immune responses to tuberculosis in Indian children
Dr. Aishwarya Venkataraman
Development and validation of a diagnostic kit for early detection of Human Papilloma Virus (HPV) infection in cervical cancer
Dr. N. Sudhakar
Latent class analysis of health-related quality of life of TB patients during & post-treatment in a Longitudinal Design
Dr. M. Vasantha
Development of a Database of Clinical Study X-rays at ICMR-NIRT, Chennai
Dr. C. Ponnuraja
HTA for implementation of cell counters for referral of suspected dengue cases at PHC settings
Dr. M. Muniyandi
The Economic evaluation of standardised treatment regimens of anti-TB drugs for patients with MDR-TB (STREAM stage-II trial)
Dr. M. Muniyandi
Social network analysis as a tool to improve active case finding at the community level in Chennai
Dr. N. Karikalan
Measuring the socio-economic risk-benefits & health-related quality of life changes associated with TB disease disclosure
Dr. N. Karikalan
Early bactericidal activity of anti-tuberculosis drugs
Dr. K.R. Uma Devi
Protecting and improving public health globally: Building laboratory, surveillance, and workforce capacity to detect, respond to, and prevent drug-resistant tuberculosis in India
Dr. K.R. Uma Devi
Identification of the latent tuberculosis-specific marker by the immunoproteomic analysis of the cell wall and membrane proteins of M. tuberculosis
Dr. K.R. Uma Devi
Accurate, Rapid, Robust, and Economical diagnostic technologies for Tuberculosis: ARREST-TB
Dr. K.R. Uma Devi
Crohn's disease in India: A multicenter study from a country where intestinal tuberculosis as well as Johne’s disease is endemic
Dr. P. Kannan
Studies on epigenome-wide alterations in alveolar macrophages during M. tuberculosis infections in a guinea pig pulmonary tuberculosis model
Dr. P. Kannan
Whole Genome Sequencing and Transcriptome analysis of M. tuberculosis clinical isolates from Bovine and Human Origin
Dr. P. Kannan
Identification of Mycobacterium tuberculosis complex (MTBC) organisms in the lymph node samples of slaughtered cattle in Chennai
Dr. P. Kannan
Dereplication-guided bio-prospecting of cyclic lipopeptides from marine Bacillus sp. for inhibition of M. tuberculosis
Dr. P. Kannan
Mentor for the project
Dr. Sagarika Devi (PI for the project)
Systems biology and immunology of the effect of tuberculosis chemoprophylaxis in HIV infection
Dr. Syed Hissar & Dr. Pavan Kumar
An open-label, three-arm, pragmatic, randomized controlled pilot study to determine the protective effect of Kabha Sura Kudineer (KSK)/ Nilavembu Kudineer (NVK) in preventing COVID-19 symptoms compared to standard Vitamin C-Zinc supplementation and to examine immune responses among healthcare workers
Dr. Pavan Kumar & Dr. Subash Babu
Identification of tuberculosis-specific biomarkers in children by the proteomic analysis of urine
Dr. D. Anbarasu & Dr. Syed Hissar
Molecular Analysis of monocyte subsets in humans infected with Mycobacterium tuberculosis
Dr. Ramalingam B
Attenuated mycobacteria-based vaccine against tuberculosis with a novel strategy for T cell priming
Dr. K.R. Uma Devi
CRISPR-mediated platform for diagnosis and rapid detection of drug resistance pattern in M. tuberculosis
Dr. K.R. Uma Devi
Functional characterization of oxidoreductases of M. tuberculosis
Dr. P. Kannan
Study on mutations associated with Pyrazinamide resistance in M. tuberculosis
Dr. P. Kannan
A cross-sectional study of the systems immunology and viral diversity of SARS-CoV-2 infection, COVID-19 disease, and Multisystem Inflammatory Syndrome in children
Dr. Pavan Kumar & Dr. Subash Babu
Characterization and durability of COVID-19 vaccine-induced immune responses in healthcare/frontline workers
Dr. Pavan Kumar & Dr. Banu Rekha
Humoral and cellular immune response among recovered COVID-19 patients: A cross-sectional study, Tiruvallur district, Chennai Corporation, Tamil Nadu, India, 2020
Dr. Pavan Kumar (Co-PI)
Role of neutralizing antibodies and inflammatory biomarkers in children with Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS)
Dr. Pavan Kumar (Co-PI)
Regional Prospective Observational Research in Tuberculosis (RePORT) - Phase 2
Dr. Pavan Kumar (Co-PI)
CYP2R1 gene polymorphisms in pulmonary tuberculosis
Dr. Ramalingam B & Dr. Harishanker
Immunomodulation of Autophagy by Vitamin D3 in macrophages infected with Mycobacterium tuberculosis
Dr. Ramalingam B
Molecular and immune profiling in adults affected with COVID-19 disease
Dr. N. Sudhakar
Accessibility Options
Screen Reader